Results 171 to 180 of about 177,876 (307)

Giant cell arteritis: a multicenter observational study in Brazil

Clinics, 2013
OBJECTIVE: To describe demographic features, disease manifestations and therapy in patients with giant cell arteritis from referral centers in Brazil.
Alexandre Wagner Silva de Souza, Karine Yoshiye Kajiyama Okamoto, Fabiano Abrantes, Bruno Schau, Ana Beatriz Santos Bacchiega, Samuel Katsuyuki Shinjo   +5 more
doaj  

Trial of Tocilizumab in Giant‐Cell Arteritis

New England Journal of Medicine, 2017
J. Stone, K. Tuckwell, S. Dimonaco, M. Klearman, M. Aringer, D. Blockmans, E. Brouwer, M. Cid, B. Dasgupta, J. Rech, C. Salvarani, G. Schett, H. Schulze-Koops, R. Spiera, S. Unizony, N. Collinson   +15 more
semanticscholar   +1 more source

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis [PDF]

, 2018
Purpose: We aimed to assess the impact of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) on the management of patients with suspected large vessel vasculitis.
Berg, Scott, Blockmans, Daniel, Briel, Matthias, Cid, Maria, Daikeler, Thomas, Fuchs, Martin, Jayne, David, Karageorgaki, Zaharenia, Kötter, Ina, Lamprecht, Peter, Luqmani, Raashid, Müller-Brand, Jan, Ng, Quinn, Prieto-González, Sergio, Raatz, Heike, Rasch, Helmut, Salvarani, Carlo, Tyndall, Alan, Walker, Ulrich, Walter, Martin, Watts, Richard   +20 more
core  

Giant cell arteritis (temporal arteritis): A report of four cases from north east India

Annals of Indian Academy of Neurology, 2008
Giant cell arteritis (GCA) is a common disease of the geriatric age group in the western world, with a prevalence of 0.2% in the fifty plus age group.
Laldinpuii Judy, Sanchetee Pratap, Borah Adityendra, Ghose Manash, Borah Nomal   +4 more
doaj  

Seronegative polyarthritis in giant cell arteritis [PDF]

, 1985
William W. Ginsburg, Marc D. Cohen, Stephen B. Hall, Randall S. Vollertsen, Gene G. Hunder   +4 more
openalex   +1 more source

Giant cell arteritis [PDF]

QJM: An International Journal of Medicine, 2020
K Shikino, M Ikusaka
openaire   +3 more sources

Preventable blindness in giant cell arteritis. [PDF]

, 1987
S P Kelly, D Argyll Robertson, Chad K Rostron   +2 more
openalex   +1 more source

The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease [PDF]

, 2018
Purpose: This study was performed to investigate the value of 18F-fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.
Melzer, Ralph, Müller-Brand, Jan, Nitzsche, Egbert, Schindler, Christian, Tyndall, Alan, Walter, Martin   +5 more
core  

Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis—Similarities and Differences

Current Rheumatology Reports, 2020
R. Watanabe, G. Berry, David H. Liang, J. Goronzy, C. Weyand   +4 more
semanticscholar   +1 more source

Visualization of cranial giant cell arteritis with [18F]FDG PET/CT: A case report

Radiology Case Reports
Giant cell arteritis is a form of large vessel vasculitis which can present with nonspecific symptoms, and if left untreated can cause significant morbidity and/or death. Early diagnosis and management are therefore paramount.
Muhammed Sarjoon Amjadeen, MBBS, Manoj Bhatt, MBBS, FRACP, FAANMS, Evyn Arnfield, MBBS, FRANZCR, FAANMS   +2 more
doaj